AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (183)

Latest Posts

About This Stock More About This Stock
Top 3 Dividend Stocks For Any Market
Video By: Marc Lichtenfeld
Sunday, June 26, 2022 5:39 PM EDT
As inflation heats up and the Fed raises interest rates, now is the time to check out AbbVie, Enterprise Product Partners, and NextEra Energy Partners.
In this video: EPD, NEP, ABBV
Watch
19 Dividend Stocks That Pay In February, May, August And November
Article By: Rick Orford
Friday, April 22, 2022 9:29 AM EDT
Looking to fill in your dividend calendar? These top dividend stocks pay quarterly.
In this article: X, ABM, ABT, AOS, APD, CAT, CL, CLX, FUL, GD, HRL, LOW, NUE, O, PG, PNR, UVV, WMT, WST, ABBV
Read
Tuesday Talk: Zig-Zag-ing Away
Article By: TalkMarkets DailyTalk
Tuesday, April 19, 2022 6:41 AM EDT
The market returned from the Good Friday long weekend by starting up then turning down then turning up, turning down, up again and down again, before closing out the day nearly unchanged.
In this article: AFL, XOM, ABBV, BITCOMP, ETH-X Also: TWTR
Read
S 3 DRIP Stocks With Rising Dividends
Article By: SureDividend
Tuesday, April 19, 2022 6:04 AM EDT
Dividend Reinvestment Plan (DRIP) stocks allow you to automatically reinvest incoming dividend payments. We discuss the prospects of three high-quality, no-fee DRIP stocks - XOM, ABBV and AFL.
In this article: AFL, XOM, ABBV
Read
2 Great Dividend Stocks To Buy Now To Help Tackle Inflation
Article By: Benjamin Rains
Friday, April 8, 2022 4:33 AM EDT
Wall Street turned its focus back to the possibility of higher interest rates as the Fed is indicating a more hawkish turn to help combat 40-year high inflation.
In this article: ABBV, VICI
Read

Latest Tweets for $ABBV

No tweets yet!

PARTNER HEADLINES

$ABBV

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/11/2020 4:12:58 AM

Just a hunch. The healthcare industry is highly regulated and Dems generally favor more regulation, making it more difficult for drugmakers to secure the necessary regulatory approvals to market new products. Regulatory changes could drastically alter a healthcare stock’s growth prospects, for instance. But I reckon I'll not sell $ABBV after holding during all the long downward spiral.

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/10/2020 2:44:59 AM

Seems health stocks should do well but a #Biden presidency will not favor this sector. $ABBV $PFE

Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
Beating Buffett 7/11/2019 1:00:14 PM

How much debt does $ABBV have?

AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
Dan Richards 6/25/2019 11:19:59 PM

$ABBV certainly sounds like a great buy.

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 6 of 6 comments